CDKN1A and hepatocellular carcinoma: It is well known that low expression of CD81 has more metastatic potential in HCC cell lines and the CDKN1A suppression facilitates cell cycle progression from the G1 to the S phase to promote tumor cell proliferation (Mazzocca et al., 2008; Di Giorgio et al., 2015).